SPARC and intervertebral disk degenerative disorder: SPARC promoter was significantly hypermethylated in patients with low back pain measured with ODI score (p < 0.01), in surgical patients (p < 0.05), and in lumbar disc degeneration based on MRI image scoring (p < 0.001) compared to IVD controls.